Sanofi to buy US biotech firm Amunix for $1 billion
newsdepo.com
Immuno-oncology firm Amunix is developing cancer therapies based on cytokines -- small proteins that play a role in controlling the immune system -- and T-cells, a type of white blood cell.Sanofi to buy US biotech firm Amunix for $1 billion
Immuno-oncology firm Amunix is developing cancer therapies based on cytokines -- small proteins that play a role in controlling the immune system -- and T-cells, a type of white blood cell. Read more